Danli Yang

Prof. Danli Yang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
SFShu Fu
Shu Fu
YLYe-Li Li
Ye-Li Li
YWYu-Ting Wu
Yu-Ting Wu
YYYun Yue
Yun Yue
ZQZhi-Qiang Qian
Zhi-Qiang Qian
DYDanli Yang
Danli Yang

1 March 2017 in Molecular Medicine Reports
Verified
Journal Article
Closed access
PDF file
YLYeli Li
Yeli Li
YWYingwan Wang
Yingwan Wang
YLYiqi Li
Yiqi Li
ZQZhiqiang Qian
Zhiqiang Qian
LZLing Zhu
Ling Zhu
DYDanli Yang
Danli Yang
Pulmonary arterial hypertension (PAH) is an insidious and progressive disease that is triggered by various cardiopulmonary diseases. Inflammation has an important role in the progression of PAH. Osthole (Ost) is a coumarin that has clear anti‑inflammatory properties. The present study aimed to investigate the effects of Ost on PAH, and to explore the mechanism underlying this effect. Using the monocrotaline (MCT)‑induced PAH rat model, the effects of Ost on PAH were investigated. Rats were subcutaneously administered a single dose of MCT (50 mg/kg) to establish the PAH model, followed by daily treatment with Ost (10 or 20 mg/kg) by gavage for 28 days. The mean pulmonary arterial pressure (mPAP) was measured and histological analysis was performed. The results demonstrated that Ost significantly decreased mPAP, and reduced thickening of the pulmonary artery, compared with in rats in the MCT group. To further determine whether the effects of Ost on MCT‑induced PAH were associated with inflammatory responses, the nuclear factor‑κB (NF‑κB) p65 signaling pathway was investigated by western blot analysis. The results demonstrated that Ost increased inhibition of the NF‑κB p65 signaling pathway. In conclusion, the results of the present study demonstrate that Ost may suppress the progression of MCT‑induced PAH in rats, which may be, at least partially, mediated through modulation of the NF‑κB p65 signaling pathway.

1 January 2018 in European Journal of Pharmacology
Verified
Journal Article
Closed access
YLYeli Li
Yeli Li
YLYiqi Li
Yiqi Li
FSFuguo Shi
Fuguo Shi
LWLina Wang
Lina Wang
LLLisheng Li
Lisheng Li
DYDanli Yang
Danli Yang

9 December 2019 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
PDF file
SFShu Fu
Shu Fu
YLYeli Li
Yeli Li
YWYuting Wu
Yuting Wu
YYYun Yue
Yun Yue
DYDanli Yang
Danli Yang

1 January 2018 in European Journal of Pharmacology
Verified
Journal Article
Closed access
YWYuting Wu
Yuting Wu
ZQZhiqiang Qian
Zhiqiang Qian
SFShu Fu
Shu Fu
YYYun Yue
Yun Yue
YLYeli Li
Yeli Li
DYDanli Yang
Danli Yang

20 November 2018 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
PDF file
YWYuting Wu
Yuting Wu
YYYun Yue
Yun Yue
SFShu Fu
Shu Fu
YLYeli Li
Yeli Li
DWDongqing Wu
Dongqing Wu
DYDanli Yang
Danli Yang